Abnova (Taiwan) Corporation
TAI: 4133.TW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taiwan Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Peiru Ji
- Employees
- 110
- Headquarters
- Taipei, Taiwan
- IPO year
- 2009
- Market cap
- NT$1.3B
- Website
- https://www.abnova.com
Loading 4133…
Loading profile data…Frequently asked questions about 4133
What does Abnova (Taiwan) Corporation (4133.TW) do?
Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. The company's products portfolio includes SARS-CoV/CoV-2, DNA and RNA, proteins/peptides, DNAxPab, beads/dyes, lysates/slides, antibody pairs/kits, antibody and tissue arrays, in situ hybridization products, systems and automations, GMP and analyte sp...
Where does 4133.TW trade?
Abnova (Taiwan) Corporation (4133.TW) trades on the Taiwan Stock Exchange.
What sector is 4133.TW in?
Abnova (Taiwan) Corporation (4133.TW) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Abnova (Taiwan) Corporation?
Peiru Ji is the chief executive officer of Abnova (Taiwan) Corporation (4133.TW).
Where is Abnova (Taiwan) Corporation headquartered?
Abnova (Taiwan) Corporation is headquartered in Taiwan.
Does 4133.TW pay a dividend?
Yes — Abnova (Taiwan) Corporation (4133.TW) paid a trailing twelve-month dividend of TWD 0.90 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4133.TW go public?
Abnova (Taiwan) Corporation (4133.TW) completed its initial public offering in 2009.